Prognos Health Empowers Faster, More Targeted Interventions with New Daily HCP Alerts Offering
NEW YORK, NY, August 15, 2024 (GLOBE NEWSWIRE) -- Prognos Health, the recognized leader in...
Prognos Health and Invitae Partner to Improve Diagnosis and Advance Novel Treatments for Rare, Genetic-Driven Disease
NEW YORK, NY, March 13, 2024 (GLOBE NEWSWIRE) -- Prognos Health, the most-trusted provider of real...
Unprecedented Access to Cancer Diagnostics Data with the Launch of Prognos Oncology
Leverages New and Exclusive Partnerships for Oncology Insights across the Community and Academic...
Clarence So and Travis May Join as Independent Board Members
Prognos Health, the most-trusted provider of real-world data (RWD), today announced the addition...
GeneDx and Prognos Health Announce Strategic Partnership to Help Rare Disease Patients More Rapidly Gain Access to Potential Treatment Options
Partnership allows commercial biopharma companies to leverage real-time data within comprehensive...
Prognos Health Raises $23 Million
New York, NY – Prognos Health, the largest real-world integrated data marketplace, has announced...
Dr. Steven Zatz Joins Prognos® Health Board of Directors
Former WebMD CEO brings a wealth of industry insight to help drive company direction and vision.
Prognos Health Named to NYC Digital Health 100 by NYCHBL
Real world data and platform company recognized among the most innovative digital health...
Survey, Whitepaper from PrognosⓇ Health and Reuters Events™ Uncovers RWD Trends in the Pharmaceutical Industry - Prognos Health
New research identifies top RWD challenges, priorities and opportunities.